Literature DB >> 9503185

A non-invasive selective assessment of type I fibre mitochondrial function using 31P NMR spectroscopy. Evidence for impaired oxidative phosphorylation rate in skeletal muscle in patients with chronic heart failure.

M van der Ent1, J A Jeneson, W J Remme, R Berger, R Ciampricotti, F Visser.   

Abstract

BACKGROUND: Skeletal muscle abnormalities contribute considerably to the clinical expression of heart failure. Deconditioning, underperfusion and an increased number of type IIb glycolytical fibres lead to early lactate production and muscle fatigue at low exercise levels. Aerobic muscle metabolism may also be impaired, as suggested by biopsy studies. Thus far, no data are available from non-invasive studies to indicate the extent of aerobic muscle dysfunction during low-grade exercise which does not induce acidosis. METHODS AND
RESULTS: Mitochondrial function of skeletal muscle during fibre type I activation was studied in 22 patients with chronic heart failure [NYHA class III, left ventricular ejection fraction 28 +/- 2%, (patients)] on ACE inhibitors, diuretics and digoxin, and in 20 normal subjects, using 31P NMR spectroscopy of a single right forearm flexor muscle during three mild intermittent exercise levels (0-40% of maximum voluntary contraction) and recovery time. At rest, the inorganic phosphate/phosphocreatine ratio was different [0.13 +/- 0.005 (patients) vs 0.09 +/- 0.002 (normal subjects), P = 0.0001]. However, intracellular pH was comparable. Local acidosis (tissue pH < 6.9) was avoided to prevent fibre type IIb activation. Calculated resting phosphate potential levels were comparable, but the slope and intercept of the linear relationship of phosphate potential and workload were significantly lower in patients than in normal subjects (11.7 +/- 0.7 vs 15.8 +/- 0.6 and 139 +/- 7 vs 196 +/- 7, patients vs normal subjects, indicating early exhaustion of intracellular energy at lower exercise levels. Also, maximum calculated workload at which tissue ADP stabilized was lower in patients than in normal subjects (88 +/- 7% vs 120 +/- 4% of maximum voluntary workload, patients vs normal subjects, P < 0.05). Time to recovery to pre-test phosphocreatine levels was prolonged by 46% in patients compared to normal subjects (P < 0.05).
CONCLUSIONS: In heart failure, oxidative fibre mitochondrial function in skeletal muscle is impaired, as reflected by the reduced phosphate potential and oxidative phosphorylation rate, early exhaustion and slowed recovery of intracellular energy reserve at workloads, which do not affect intracellular pH.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9503185     DOI: 10.1053/euhj.1997.0727

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

Review 1.  Role of phosphate and calcium stores in muscle fatigue.

Authors:  D G Allen; H Westerblad
Journal:  J Physiol       Date:  2001-11-01       Impact factor: 5.182

2.  Detection of calf muscle alterations in patients with chronic heart failure by P magnetic resonance spectroscopy: Impaired adaptation to continuous exercise.

Authors:  Ichiro Nakae; Kenichi Mitsunami; Shinro Matsuo; Toshiro Inubushi; Shigehiro Morikawa; Terue Koh; Minoru Horie
Journal:  Exp Clin Cardiol       Date:  2005

Review 3.  Impaired Exercise Tolerance in Heart Failure: Role of Skeletal Muscle Morphology and Function.

Authors:  Wesley J Tucker; Mark J Haykowsky; Yaewon Seo; Elisa Stehling; Daniel E Forman
Journal:  Curr Heart Fail Rep       Date:  2018-12

Review 4.  Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?

Authors:  Nils Bomer; Mario G Pavez-Giani; Niels Grote Beverborg; John G F Cleland; Dirk J van Veldhuisen; Peter van der Meer
Journal:  J Intern Med       Date:  2022-02-09       Impact factor: 13.068

Review 5.  Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?

Authors:  Suzanne N Voorrips; Huitzilihuitl Saucedo-Orozco; Pablo I Sánchez-Aguilera; Rudolf A De Boer; Peter Van der Meer; B Daan Westenbrink
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

Review 6.  Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?

Authors:  Kirsten T Nijholt; Pablo I Sánchez-Aguilera; Suzanne N Voorrips; Rudolf A de Boer; B Daan Westenbrink
Journal:  Eur J Heart Fail       Date:  2022-01-09       Impact factor: 17.349

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.